Neurogenic Inflammation: Clinical Trials

1 trial for Neurogenic Inflammation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Neurogenic Inflammation: new trials by email Literature Review of Neurogenic Inflammation trials Research Report on Neurogenic Inflammation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome
BoNT-A, Placebo - Carpal Tunnel Syndrome, Neurogenic Inflammation
Phase 2UnknownFrancesco Bono1642022-05-252022-06-09

Narrower conditions

Carpal Tunnel Syndrome (1)  ·  Neuralgia (1)  ·  Pain (1)

Broader conditions

Cumulative Trauma Disorders (1)  ·  Inflammation (1)  ·  Median Neuropathy (1)  ·  Mononeuropathies (1)  ·  Nerve Compression Syndromes (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Peripheral Nervous System Diseases (1)  ·  Signs and Symptoms (1)  ·  Sprains and Strains (1)  ·  Wounds and Injuries (1)

Interventions

incobotulinumtoxinA (1)

Sponsors

Francesco Bono (1)

Countries

Italy (1)

Results publications

PMID 11402097, PMID 15030944, PMID 15234492, PMID 18003941, PMID 18289791, PMID 18546285, PMID 24641437, PMID 25378457, PMID 26866499, PMID 26947719, PMID 27435748, PMID 27751557, PMID 28205574, PMID 28375915, PMID 4139420, PMID 8080219, PMID 8245050